421.75
0.00%
-0.010
After Hours:
421.75
Idexx Laboratories Inc Stock (IDXX) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
6.93%
964.10
|
901.60 | 915.53 | 943.63 | 900.20 |
Cost Of Revenue |
1.17%
371.02
|
375.43 | 367.55 | 370.78 | 357.22 |
Gross Profit |
12.72%
593.07
|
526.17 | 547.98 | 572.85 | 542.97 |
Operating Expenses
|
4.72%
294.11
|
280.87 | 272.70 | 276.71 | 262.57 |
Interest Income/Expense |
14.61%
7.911
|
9.265 | 8.647 | 10.54 | 13.13 |
Benefits Costs and Expenses |
1.01%
668.62
|
661.93 | 647.64 | 657.70 | 632.51 |
Costs And Expenses |
1.01%
668.62
|
661.93 | 647.64 | 657.70 | 632.51 |
Provision For Loan, Lease, And Other Losses |
1,639%
1.53
|
0.088 | 1.607 | 1.532 | 2.325 |
Operating Income/Loss |
21.87%
298.96
|
245.30 | 275.28 | 296.14 | 280.40 |
Income/Loss From Continuing Operations Before Tax |
23.29%
295.48
|
239.67 | 267.89 | 285.93 | 267.69 |
Income Tax Expense/Benefit, Deferred |
92.34%
-2.571
|
-33.56 | -1.817 | -9.175 | -3.757 |
Income Tax Expense/Benefit |
32.68%
59.90
|
45.15 | 55.66 | 61.69 | 53.63 |
Income/Loss From Continuing Operations After Tax |
21.11%
235.58
|
194.52 | 212.23 | 224.24 | 214.05 |
Net Income/Loss
|
21.11%
235.58
|
194.52 | 212.23 | 224.24 | 214.05 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.04M%
83.10
|
0.008 | 83.10 | 83.09 | 82.99 |
Diluted Average Shares |
699.74K%
83.96
|
-0.012 | 83.99 | 83.98 | 83.96 |
Basic Earnings Per Share |
21.37%
2.84
|
2.34 | 2.55 | 2.70 | 2.58 |
Diluted Earnings Per Share |
21.65%
2.81
|
2.31 | 2.53 | 2.67 | 2.55 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):